MEDXF - Medexus Pharmaceuticals (MEDXF) CEO Ken d'Entremont on Q4 2022 Results - Earnings Call Transcript

Medexus Pharmaceuticals Inc. (MEDXF) Q4 2022 Earnings Conference Call June 23, 2022 8:00 am ET Company Participants Ken d’Entremont - Chief Executive Officer Marcel Konrad - Chief Financial Officer Victoria Rutherford - Investor Relations, Adelaide Capital Conference Call Participants Andre Uddin - Research Capital Scott Henry - Roth Capital Justin Keywood - Stifel Prasath Pandurangan – Bloom Burton Presentation Operator Good morning ladies and gentlemen and welcome to the Medexus Pharmaceuticals fourth quarter 2022 earnings call. At this time, all participants have been placed on a listen-only mode and the floor will be open for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, Ms. Victoria Rutherford. Victoria, the floor is yours. Victoria Rutherford Thank you and good morning everyone. Welcome to the Medexus Pharmaceuticals fourth quarter and fiscal year 2022 earnings call. On the call this morning are Ken

For further details see:

Medexus Pharmaceuticals (MEDXF) CEO, Ken d'Entremont on Q4 2022 Results - Earnings Call Transcript